Schneider, Andrea http://orcid.org/0000-0002-4674-7244
Winarni, Tri Indah
Cabal-Herrera, Ana María http://orcid.org/0000-0002-4879-4896
Bacalman, Susan
Gane, Louise
Hagerman, Paul
Tassone, Flora
Hagerman, Randi
Article History
Received: 19 September 2016
Revised: 19 May 2020
Accepted: 22 May 2020
First Online: 23 June 2020
Conflict of interest
: R.H. has received funding from Zynerba, Ovid, and the Azrieli Foundation for carrying out treatment studies in patients with fragile X syndrome (FXS). She has also consulted with Fulcrum, Ovid, and Zynerba regarding treatment studies in individuals with FXS. F.T. has received funds from Asuragen and Zynerba for studies in FXS and associated disorders.